MARCH 2024
Discover the 8 selected startups of this fourth batch, which will benefit from the program during the next months
Level 1 winners
Level 2 winners
Level 3 winners
SEPTEMBER 2023
Discover the 9 selected startups of this third batch, which will benefit from the program during the next months
Level 1 winners
Level 2 winners
Neuria Digital Therapeuthics
Description
Neuria develops evidence-based, gamified, digital therapeutics interventions to improve (over)consumption behaviors and addictions by restoring healthy brain reward responses to environmental cues.
Neuria is a spinoff of the Neurology Unit of the University and Hospital of Fribourg developing digital therapeutic interventions for behavioral change and neuropsychiatric remediation. Our digital therapy is a true game-changer in the field of overconsumption behaviors and addiction. This is demonstrated by our first target condition: overweight and obesity.
We have identified specific cognitive tasks whose repeated practice induces highly targeted brain plasticity in the reward brain regions, resulting in a progressive reduction in the attractiveness of target foods items (the underlying human-machine interface was patented by the founder of Neuria). One month of training with our software induces long-lasting reduction in the attractiveness of the targeted unhealthy palatable foods: eating less of them becomes easier, their consumption decreases, weight decreases, and health improves.
Level 3 winners
FEBRUARY 2023
Discover the 7 selected startups of this second batch, which will benefit from the program during the next months
Level 1 winners
Level 2 winners
SEPTEMBER 2022 WINNERS
Discover the first 10 selected startups in digital health which will benefit from the program during the next months
Level 1 winners
GLUCOPLAY
Description
Glucoplay is a game-based mobile application with signaling function that helps the children to better understand their condition due to diabetes. The game educates them to take responsibility for themselves and their health, and moreover to perform certain actions for supporting their condition in a safe state in order to live a full life without social restrictions.
Neuria Digital Therapeuthics
Description
Neuria develops evidence-based, gamified, digital therapeutics interventions to improve (over)consumption behaviors and addictions by restoring healthy brain reward responses to environmental cues.
Neuria is a spinoff of the Neurology Unit of the University and Hospital of Fribourg developing digital therapeutic interventions for behavioral change and neuropsychiatric remediation. Our digital therapy is a true game-changer in the field of overconsumption behaviors and addiction. This is demonstrated by our first target condition: overweight and obesity.
We have identified specific cognitive tasks whose repeated practice induces highly targeted brain plasticity in the reward brain regions, resulting in a progressive reduction in the attractiveness of target foods items (the underlying human-machine interface was patented by the founder of Neuria). One month of training with our software induces long-lasting reduction in the attractiveness of the targeted unhealthy palatable foods: eating less of them becomes easier, their consumption decreases, weight decreases, and health improves.
Vitalize Dx
Description
VitalizeDx is an innovative startup dedicated to preventative medicine operating in the longevity space. At VitalizeDx, we provide accessible actionable diagnostics for personalized welllness through 16 proprietary salivary biomarkers and bundled personalized nutriceutical programs for the areas of immunity, vitality, metabolism and strength.
Level 2 winners
biped.ai
Description
biped is a smart shoulder-worn harness that uses self-driving technology to guide blind and partially-sighted people with 3D sounds.
VISIT WEBSITE
Description
ATREON is a game-changing digital biomarker for arthritis (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis). Thanks to image recognition and artificial intelligence, ATREON is able to detect and monitor inflammation and swelling in joints using a smartphone picture from the hand. This technology has a significant potential to improve arthritis monitoring and patient care. We aim to develop an app-based monitoring tool that people can regularly and easily use to monitor their disease activity.
Gossik
Description
Gossik is the digital productivity assistant that helps people with ADHD structure their day and get their things done.
Level 3 winners
Ocumeda
Description
Ocumeda is a telemedicine startup that offers easy, quick and affordable access to eye care at the highest medical standards. Early detection could prevent 75% of blindness worldwide. Hence, we aim to prevent unnecessary vision loss - globally. We do this in a hybrid offline and online customer interaction in combination with AI.
Genknowme
Description
We are the swiss epigenetic company estimating the environmental and lifestyle impacts on biological age, an innovative measure of premature aging and overall health.